{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:13:51Z","timestamp":1790648031947,"version":"4.1.0"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1005148","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T14:02:16Z","timestamp":1441116136000},"page":"e1005148","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":70,"title":["Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer"],"prefix":"10.1371","volume":"11","author":[{"given":"Michael H.","family":"Matho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Schlossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Rafii-El-Idrissi","family":"Benhnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kaever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Buller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Doronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjoern","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Crotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk M.","family":"Zajonc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,1]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/infdis\/142.4.636","article-title":"A reality in our time\u2014certification of the global eradication of smallpox","volume":"142","author":"PF Wehrle","year":"1980","journal-title":"J Infect Dis"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"S Crotty","year":"2003","journal-title":"J Immunol"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"E Hammarlund","year":"2003","journal-title":"Nat Med"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jama.1970.03170160031005","article-title":"Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968","volume":"212","author":"JM Lane","year":"1970","journal-title":"Jama"},{"key":"ref5","first-page":"1460","article-title":"Smallpox and its eradication","author":"F Fenner","year":"1988"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"e1003756","DOI":"10.1371\/journal.ppat.1003756","article-title":"An increasing danger of zoonotic orthopoxvirus infections","volume":"9","author":"SN Shchelkunov","year":"2013","journal-title":"PLoS Pathog"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"e55808","DOI":"10.1371\/journal.pone.0055808","article-title":"Emergence of cowpox: study of the virulence of clinical strains and evaluation of antivirals","volume":"8","author":"S Duraffour","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000331426","article-title":"Necrotic ulcerated lesion in a young boy caused by cowpox virus infection","volume":"3","author":"AL Favier","year":"2011","journal-title":"Case Rep Dermatol"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1586\/erv.11.46","article-title":"The strategic use of novel smallpox vaccines in the post-eradication world","volume":"10","author":"JW Golden","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"KJ Stittelaar","year":"2005","journal-title":"J Virol"},{"issue":"9457","key":"ref11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(05)70234-8","article-title":"Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial","volume":"365","author":"RN Greenberg","year":"2005","journal-title":"Lancet"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nm916","article-title":"Clonal vaccinia virus grown in cell culture as a new smallpox vaccine","volume":"9","author":"R Weltzin","year":"2003","journal-title":"Nat Med"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.vaccine.2009.11.030","article-title":"A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE","volume":"28","author":"A von Krempelhuber","year":"2010","journal-title":"Vaccine"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.vaccine.2007.11.095","article-title":"Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination","volume":"26","author":"DW Grosenbach","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"JW Hooper","year":"2003","journal-title":"Virology"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virol.2007.09.029","article-title":"Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens","volume":"371","author":"P Sakhatskyy","year":"2008","journal-title":"Virology"},{"issue":"25\u201326","key":"ref17","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.vaccine.2004.02.034","article-title":"Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB\/c mice from a lethal intranasal poxvirus challenge","volume":"22","author":"DJ Pulford","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/infdis\/jiq017","article-title":"Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge","volume":"203","author":"LA Hirao","year":"2011","journal-title":"J Infect Dis"},{"issue":"19","key":"ref19","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"C Fogg","year":"2004","journal-title":"J Virol"},{"issue":"18","key":"ref20","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"DH Davies","year":"2005","journal-title":"J Virol"},{"issue":"40","key":"ref21","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","article-title":"A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge","volume":"28","author":"GW Buchman","year":"2010","journal-title":"Vaccine"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/pmic.200600926","article-title":"Proteome-wide analysis of the serological response to vaccinia and smallpox","volume":"7","author":"DH Davies","year":"2007","journal-title":"Proteomics"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"MM Putz","year":"2006","journal-title":"Nat Med"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/JVI.56.2.482-488.1985","article-title":"Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus","volume":"56","author":"JF Rodriguez","year":"1985","journal-title":"J Virol"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1128\/JVI.01854-07","article-title":"Vaccination of BALB\/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge","volume":"82","author":"A Berhanu","year":"2008","journal-title":"J Virol"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1128\/JVI.62.10.3772-3778.1988","article-title":"Vaccinia virus gene D8 encodes a virion transmembrane protein","volume":"62","author":"EG Niles","year":"1988","journal-title":"J Virol"},{"issue":"19","key":"ref27","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1128\/JVI.01149-06","article-title":"Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein","volume":"80","author":"E Brown","year":"2006","journal-title":"J Virol"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","article-title":"Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo","volume":"74","author":"CL Lin","year":"2000","journal-title":"J Virol"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"EJ Wolffe","year":"1995","journal-title":"Virology"},{"issue":"17","key":"ref30","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1128\/JVI.00906-07","article-title":"Characterization of chimpanzee\/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model","volume":"81","author":"Z Chen","year":"2007","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1743-422X-10-229","article-title":"Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response","volume":"10","author":"N Paran","year":"2013","journal-title":"Virol J"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1128\/JVI.70.6.3753-3762.1996","article-title":"Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene","volume":"70","author":"RL Roper","year":"1996","journal-title":"J Virol"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3851\/IMP1573","article-title":"Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model","volume":"15","author":"MM McCausland","year":"2010","journal-title":"Antivir Ther"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0042-6822(92)90535-W","article-title":"A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope","volume":"188","author":"M Engelstad","year":"1992","journal-title":"Virology"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1128\/JVI.66.3.1610-1621.1992","article-title":"Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress","volume":"66","author":"SA Duncan","year":"1992","journal-title":"J Virol"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1128\/JVI.66.12.7217-7224.1992","article-title":"Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope","volume":"66","author":"SN Isaacs","year":"1992","journal-title":"J Virol"},{"issue":"Pt 1","key":"ref37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1099\/0022-1317-83-1-195","article-title":"The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface","volume":"83","author":"H van Eijl","year":"2002","journal-title":"The Journal of general virology"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/viro.2000.0260","article-title":"The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles","volume":"271","author":"H van Eijl","year":"2000","journal-title":"Virology"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0042-6822(92)90313-E","article-title":"Characterization of vaccinia virus glycoproteins by monoclonal antibody precipitation","volume":"187","author":"LG Payne","year":"1992","journal-title":"Virology"},{"key":"ref40","first-page":"2502","article-title":"The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains","author":"HP Su","year":"2010","journal-title":"J Virol"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/JVI.72.5.4192-4204.1998","article-title":"The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus","volume":"72","author":"RL Roper","year":"1998","journal-title":"J Virol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.1998.9103","article-title":"Role for the vaccinia virus A36R outer envelope protein in the formation of virus-tipped actin-containing microvilli and cell-to-cell virus spread","volume":"244","author":"EJ Wolffe","year":"1998","journal-title":"Virology"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/JVI.75.1.303-310.2001","article-title":"The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein","volume":"75","author":"EJ Wolffe","year":"2001","journal-title":"J Virol"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virol.2010.03.017","article-title":"There is an A33-dependent mechanism for the incorporation of B5-GFP into vaccinia virus extracellular enveloped virions","volume":"402","author":"WM Chan","year":"2010","journal-title":"Virology"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.virol.2010.09.021","article-title":"The inability of vaccinia virus A33R protein to form intermolecular disulfide-bonded homodimers does not affect the production of infectious extracellular virus","volume":"408","author":"WM Chan","year":"2010","journal-title":"Virology"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement","volume":"83","author":"MR Benhnia","year":"2009","journal-title":"J Virol"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3851\/IMP1717","article-title":"Protective murine and human monoclonal antibodies against eczema vaccinatum","volume":"16","author":"Y Tomimori","year":"2011","journal-title":"Antivir Ther"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"MC Galmiche","year":"1999","journal-title":"Virology"},{"issue":"21","key":"ref49","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"S Lustig","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/JVI.02152-12","article-title":"Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine","volume":"87","author":"MR Benhnia","year":"2013","journal-title":"J Virol"},{"issue":"23","key":"ref51","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1128\/JVI.01593-09","article-title":"Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5","volume":"83","author":"MR Benhnia","year":"2009","journal-title":"J Virol"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"e20597","DOI":"10.1371\/journal.pone.0020597","article-title":"Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors","volume":"6","author":"ME Cohen","year":"2011","journal-title":"PLoS One"},{"issue":"19","key":"ref53","doi-asserted-by":"crossref","first-page":"11339","DOI":"10.1128\/JVI.01491-14","article-title":"Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in L1 protein","volume":"88","author":"T Kaever","year":"2014","journal-title":"J Virol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.bi.59.070190.002255","article-title":"Antibody-antigen complexes","volume":"59","author":"DR Davies","year":"1990","journal-title":"Annu Rev Biochem"},{"issue":"15","key":"ref55","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1128\/JVI.00836-12","article-title":"Structural and biochemical characterization of the vaccinia virus envelope protein D8 and its recognition by the antibody LA5","volume":"86","author":"MH Matho","year":"2012","journal-title":"Journal of virology"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.virol.2007.06.042","article-title":"Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein","volume":"368","author":"HP Su","year":"2007","journal-title":"Virology"},{"issue":"4","key":"ref57","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1006\/jmbi.1993.1648","article-title":"Shape complementarity at protein\/protein interfaces","volume":"234","author":"MC Lawrence","year":"1993","journal-title":"J Mol Biol"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1073\/pnas.93.1.13","article-title":"Principles of protein-protein interactions","volume":"93","author":"S Jones","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.virol.2010.10.019","article-title":"Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus","volume":"409","author":"X Meng","year":"2011","journal-title":"Virology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-61779-876-4_13","article-title":"Generation and characterization of monoclonal antibodies specific for vaccinia virus","volume":"890","author":"X Meng","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"7","key":"ref61","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1128\/JVI.02244-07","article-title":"Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine","volume":"82","author":"MR Benhnia","year":"2008","journal-title":"J Virol"},{"issue":"1\u20132","key":"ref62","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jim.2009.08.009","article-title":"Cloning and expression of murine Ig genes from single B cells","volume":"350","author":"T Tiller","year":"2009","journal-title":"J Immunol Methods"},{"issue":"Web Server issue","key":"ref63","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume":"36","author":"X Brochet","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"Pt 4","key":"ref64","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1107\/S0907444910048675","article-title":"iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM","volume":"67","author":"TG Battye","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 4","key":"ref65","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1107\/S090744491003982X","article-title":"An introduction to data reduction: space-group determination, scaling and intensity statistics","volume":"67","author":"PR Evans","year":"2011","journal-title":"Acta crystallographica Section D, Biological crystallography"},{"issue":"Pt 5","key":"ref66","first-page":"760","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","year":"1994","journal-title":"Acta crystallographica Section D, Biological crystallography"},{"issue":"Pt 4","key":"ref67","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"AJ McCoy","year":"2007","journal-title":"J Appl Crystallogr"},{"issue":"Pt 4","key":"ref68","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"P Emsley","year":"2010","journal-title":"Acta crystallographica Section D, Biological crystallography"},{"issue":"Pt 7","key":"ref69","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1107\/S0907444903007947","article-title":"A statistic for local intensity differences: robustness to anisotropy and pseudo-centering and utility for detecting twinning","volume":"59","author":"JE Padilla","year":"2003","journal-title":"Acta crystallographica Section D, Biological crystallography"},{"issue":"Pt 1","key":"ref70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"VB Chen","year":"2010","journal-title":"Acta crystallographica Section D, Biological crystallography"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1005148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T17:21:40Z","timestamp":1599499300000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1005148"}},"subtitle":[],"editor":[{"given":"David Hugh","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,1]]},"references-count":70,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1005148","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,1]]}}}